Back to search results
NCT07631598

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Not Yet Recruiting
NAAges 18+InterventionalHealth services
Montefiore Medical Center
~512 participants
Updated 2026-06-23 on ClinicalTrials.gov
What's tested:Standard of Care ReferralLow Threshold Buprenorphine

At a glance

Recruiting sites
0 of 8 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
3-month Buprenorphine treatment retention (3-month retention)
Measured over Between baseline and 1-month following intervention, and between baseline and 3-months following intervention

Conditions

Opioid Use Disorder
Opioid Use Disorder, Severe
Opioid Use Disorder, Moderate

Explore related trials

Opioid Use Disorder

Where it's being run

8 sites across 8 states
California1
District of Columbia1
Louisiana1
Minnesota1
New Mexico1
Oregon1
South Carolina1
Wisconsin1

Study leadership

  • Aaron D Fox, MD, MS · PRINCIPAL_INVESTIGATOR · Albert Einstein College of Medicine

Who to contact

Megan M Ghiroli
[email protected]
12036068136
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • 3-month Buprenorphine treatment retention (3-month retention)Between baseline and 1-month following intervention, and between baseline and 3-months following intervention

    Buprenorphine (BUP) treatment retention will be defined as having an active buprenorphine prescription between baseline and 1-month and between the 1-month (days 1-30) and 3-month (days 31-90) time points. Participants will be asked to provide evidence of BUP prescriptions at study visits (i.e., confirmed prescriptions). If a participant receives a second BUP prescription before the 1-month follow-up and the number of days dispensed covers dates after day 30 (i.e., carries over into the 31-90 days interval), this participant will have met the primary outcome. The primary outcome will require at least one day of an active BUP prescription based on confirmed prescriptions within the 2 time-points. BUP treatment retention will be summarized as a binary ("Yes/No") variable. The number/percentage of participants who are retained at each timepoint will be summarized by arm. BUP treatment retention is the primary measure of effectiveness.